Angel investor
Every published round Kerr Neilson took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Omniscient Neurotechnology | Series B | 19 Jul 2021 | $40m | Participant | Crunchbase News, Startup Daily |
Companies Kerr Neilson has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Omniscient Neurotechnology | Neuroscience startup using AI to map the brain's connections from MRI scans so neurosurge… | 19 Jul 2021, Series B | 1 | 0 |
Fund closes reported for Kerr Neilson, as distinct from the investments it has made.
Companies Kerr Neilson has backed that another company then bought. An exit for the holding, not a deal Kerr Neilson did.
| Role | Organisation | Sources |
|---|---|---|
| No role recorded yet. Kerr Neilson has been mentioned, but not yet attached to an organisation. Know their role? | ||
Stories naming Kerr Neilson. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Sydney medtech Omniscient Neurotechnology, which applies machine learning to mapping brain networks, has reportedly raised a $40 million Series B valuing it at $400 million, with backers including Gina Rinehart, Gretel Packer, Kerr Neilson and Will Vicars.
Also Crunchbase News